RCN2 and cancer: Among them, KIF23 (kinesin family member 23) (log-rank p-value = 0.015 HR = 3,69 Fig. 5D), STMN1 (stathmin 1) (log-rank p-value = 0.012 HR = 3,49 Fig. 5E), MECOM (MDS1 and EVI1 complex locus) (log-rank p-value = 0.038 HR = 2.80 Fig. 5F), RCN2 (Reticulocalbin-2) (log-rank p-value = 0.034 HR = 2.86 Fig. 5G) were highly expressed in cancer samples, while 2 were decreased in cancer samples: LONRF3 (LON peptidase N-terminal domain and ring finger 3) (log-rank p-value = 0.013 HR = 0.31 Fig. 5H), MBNL3 (muscle blind like splicing regulator 3) (log-rank p-value = 0.015 HR = 0.32 Fig. 5I).